The GDF-15 evaluation in bladder cancer cell lines suggested that its expression could be reduced in bladder tumors, possibly due to DNA hypermethylation as well p53 inactivation in bladder cancer cells [226]. The gene discussed is TP53; the disease is urinary bladder carcinoma.